Long-term Evobrutinib Safe, Effective in Relapsing MS & Managing Life With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib appeared to safely and effectively reduced relapse rates in adults with relapsing MS for up to 2.5 years.

He also reads “There’s No Such Thing as Perfect”, a column by Jamie Hughes.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/